Búsqueda de un proyecto
Otra(s) opcion(es) de búsqueda
54 Resultado(s)
Financiado por un miembro del IRDiRC = 
Miembro de una ERN = 
Proyectos de investigación
ALEMANIA
Baden-Württemberg
HEIDELBERG
INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie
ALEMANIA
Nordrhein-Westfalen
KÖLN
Molecular basis for tumor suppression and spontanous regression in neuroblastoma
Universitätsklinikum Köln
Pädiatrische Onkologie und Hämatologie
ALEMANIA
Sachsen
LEIPZIG
NB-MolBiol-2020: Study on the clinical significance of cell biological parameters in diagnostics, prognosis and therapy for neuroblastoma patients
Zentrum für Frauen- und Kindermedizin am Universitätsklinikum Leipzig
Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie
AUSTRIA
SALZBURG
SALZBURG
Adjuvant multimodal metabolic therapy of neuroblastoma
Universitätsklinikum der Paracelsus Medizinischen Privatuniversität
Universitätsklinik für Kinder- und Jugendheilkunde
AUSTRIA
WIEN
WIEN
BRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors - AT
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Kinder- und Jugendheilkunde
AUSTRIA
WIEN
WIEN
ITCC-P4: Pediatric Preclinical Proof of Concept Platform - AT
Medizinische Universität Wien
Institut für Krebsforschung
AUSTRIA
WIEN
WIEN
Bridging cell states and interactions in sympatho-adrenal development for curing neural crest tumors
Medizinische Universität Wien
AUSTRIA
WIEN
WIEN
LIQUIDHOPE: Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastomas - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute
AUSTRIA
WIEN
WIEN
PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute
AUSTRIA
WIEN
WIEN
A Post-Authorisation Safety Study Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute
AUSTRIA
WIEN
WIEN
Ultra-high-risk pediatric cancer - combinatorial drivers and therapeutic targets for precision medicine
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute
COREA DEL SUR
KOREA, REPUBLIC OF
SEOUL
Elimination of Hypoxia Inducible Factor 2 (HIF-2) in neuroblastoma tumor stem cells to stop its metastasis
Seoul National University Hospital
Molecular Diagnostics Laboratory
ESPAÑA
Cataluña
BARCELONA
Análisis de KIF11 como nueva diana terapéutica en neuroblastoma
Vall d'Hebron Institut de Recerca VHIR
Grupo de investigación traslacional en cáncer en la infancia y la adolescencia
ESPAÑA
Madrid
MADRID
Terapia para el tratamiento de neuroblastoma basada en el uso del sistema de edición génica CRISPR/Cas9
Centro Nacional de Investigaciones Oncológicas (CNIO)
Unidad de Citogenética Molecular
ESPAÑA
Madrid
MADRID
Combinación de nanomedicina e inmunoterapia para el tratamiento del neuroblastoma
Hospital Infantil Universitario Niño Jesús
Servicio de Oncohematología
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Drug repurposing screening for rare and neglected diseases
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Focal sustained release chemotherapy-loaded biomaterials at tumor sites
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Targeting bet-bromodomains in neuroblastoma
Institution: Information not provided - US
FINLANDIA
Finland
HELSINKI
Lessons learned from the embryo to help understand neuroblastoma formation
University of Helsinki
Department of Biochemistry and Developmental Biology
FRANCIA
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Genetics and molecular bases of central hypoventilation syndromes (Ondine's Curse)
Institution: Information not provided - FR
FRANCIA
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Genetics and molecular bases of malformative syndromes with tumour predisposition
Institution: Information not provided - FR
FRANCIA
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers - FR
Institution: Information not provided - FR
FRANCIA
AUVERGNE-RHONE-ALPES
LYON
Metastatic program of neuroblastoma: elucidating the molecular dialogues of tumor cells with the embryonic microenvironment
Institut NeuroMyoGène
NEURO-DÉVELOPPEMENT, CANCER ET SIGNALISATION
FRANCIA
ILE-DE-FRANCE
PARIS
LIQUIDHOPE: Advancing liquid biopsies for monitoring and personalized treatment of children with neuroblastomas - FR
CLCC Institut Curie
Institut Curie
FRANCIA
ILE-DE-FRANCE
VILLEJUIF
BRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors - FR (Partener 1)
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent
SUECIA
Region Stockholm
STOCKHOLM
Novel targeted therapy for childhood cancer with emphasis on Wip-1 in medulloblastoma and neuroblastoma
Karolinska Institutet - Solna
Department of Women's and Children's Health
SUECIA
Region Stockholm
STOCKHOLM
INTENT: innovative approach for treatment of neuroblastoma and medulloblastoma
Karolinska Institutet - Solna
Department of microbiology, tumor and cell biology
SUIZA
Suisse Romande
LAUSANNE
Deciphering the functional role of ALK and TWIST1 in neuroblastoma development and progression
CHUV
Institut universitaire de Pathologie
SUIZA
Suisse Romande
LAUSANNE
Mechanisms of Transcription Factors-mediated chromatin regulation in pediatric tumors development
CHUV
Institut universitaire de Pathologie
ALEMANIA
Hamburg
HAMBURG
International HIT-MED Registry (I-HIT-MED) for Children, Adolescents, and Adults With Medulloblastoma, Ependymoma, Pineoblastoma, CNS-primitive Neuroectodermal Tumour
UKE - Universitätsklinikum Hamburg-Eppendorf
Klinik und Poliklinik für Pädiatrische Hämatologie und Onkologie
ALEMANIA
Nordrhein-Westfalen
ESSEN
HIT-REZ-REGISTRY: Multinational multicenter registry for Children, adolescent and young adult with therapy-refractory, progressive or recurrent medulloblastoma, pineoblastoma, CNS primitive neuroectodermal tumor (CNS PNET) and ependymoma
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie
SUIZA
Suisse Alémanique
WINTERTHUR
Brain Tumor Detection and Classification from a Single MRI Slice Using Convolutional Neural Networks
Kantonsspital Winterthur
Institut für Radio-Onkologie
ALEMANIA
Baden-Württemberg
HEIDELBERG
ERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
A Quality Improvement Project to Implement Psychosocial Care Standards in Clinical Practice in Pediatric Oncology "My Logbook! - I Know my Way Around!" Development and Evaluation of a Consensus and Evidence Based Psychosocial Therapy Tool in a Preliminary Psychosocial Study on Therapy Optimization - AT
Institution: Information not provided - AT
AUSTRIA
WIEN
WIEN
PanCareSurPass: PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors - AT
Gesundheit Österreich GmbH
AUSTRIA
WIEN
WIEN
Christian Doppler Laboratory for Next Generation CAR-T Cells
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute
BELGICA
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
Follow-up of Fertility in Young Adults Who Did or Did Not Store Testicular Tissue Before Gonadotoxic Treatment for Fertility Preservation
Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Brussel (UZ Brussel)
CANADA
Ontario
TORONTO
Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: the kidscanseq study
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Personalized whole body staging for children with cancer: a solution to the conundrum of long-term side effects from ct and pet/ct scans
Institution: Information not provided - US
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
Project 1: optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.
Institution: Information not provided - US
FRANCIA
ILE-DE-FRANCE
ORSAY
DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay
ITALIA
VENETO
PADOVA
Modulating BMP axis to prevent muscle loss, dismantling of NMJ and denervation in cancer cachexia
Venetian Institute of Molecular Medicine
Fondazione per la ricerca Biomedica avanzata ONLUS
Proyectos de investigación multicéntricos
- Deutsches Krebsforschungszentrum
- KITZ - Hopp-Kindertumorzentrum Heidelberg
- Institution: Information not provided - DE
- St. Anna Kinderkrebsforschung
- Children's Cancer Research Institute
- Institution: Information not provided - ES
- University College Dublin
- Systems Biology Ireland
- Institution: Information not provided - DE
- Institution: Information not provided - IT
- Fondazione IRCCS Istituto Nazionale dei Tumori
- S.S. di Epidemiologia Valutativa
- Fondazione IRCCS Istituto Nazionale dei Tumori
- S.S. di Epidemiologia Valutativa
- Northern Institute for Cancer Research, Medical School, Newcastle University
- Northern Institute for Cancer Research
- Institut Curie
- Macromolécules et Microsystèmes en Biologie et en Medecine
ALEMANIA
Baden-Württemberg
HEIDELBERG
BRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors
ALEMANIA
Berlin
ADDRESS: NOT PROVIDED - DE
LIQUIDHOPE:: Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastomas
AUSTRIA
WIEN
WIEN
ONTHETRRAC: Overcoming Neuroblastoma Tumour HETerogeneity, Resistance and RecurrAnCe
ESPAÑA
Madrid
ADDRESS: NOT PROVIDED - ES
PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers
IRLANDA
County Dublin
DUBLIN 4
ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours
ALEMANIA
Berlin
ADDRESS: NOT PROVIDED - DE
TORPEDO: Targeting Of Resistance in PEDiatric Oncology
ITALIA
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
TRANSCAN-2: Aligning national/regional translational cancer research programmes and activities
ITALIA
LOMBARDIA
MILANO
RARECARE: surveillance of rare cancers in Europe
ITALIA
LOMBARDIA
MILANO
RARECARENet: Information network on rare cancers
REINO UNIDO (EL)
Tyne & Wear
NEWCASTLE UPON TYNE
EPOC: European paediatric oncology off-patent medicines consortium
FRANCIA
ILE-DE-FRANCE
ORSAY